Selena Simmons-Duffin
Selena Simmons-Duffin reports on health policy for NPR.
She has worked at NPR for ten years as a show editor and producer, with one stopover at WAMU in 2017 as part of a staff exchange. For four months, she reported local Washington, DC, health stories, including a secretive maternity ward closure and a gesundheit machine.
Before coming to All Things Considered in 2016, Simmons-Duffin spent six years on Morning Edition working shifts at all hours and directing the show. She also drove the full length of the U.S.-Mexico border in 2014 for the "Borderland" series.
She won a Gracie Award in 2015 for creating a video called "Talking While Female," and a 2014 AAAS Kavli Science Journalism Award for producing a series on why you should love your microbes.
Simmons-Duffin attended Stanford University, where she majored in English. She took time off from college to do HIV/AIDS-related work in East Africa. She started out in radio at Stanford's radio station, KZSU, and went on to study documentary radio at the Salt Institute, before coming to NPR as an intern in 2009.
She lives in Washington, DC, with her spouse and kids.
-
Confused By CDC's Latest Mask Guidance? Here's What We've LearnedThe Centers for Disease Control and Prevention shifted its stance this week on the need to wear masks if you're vaccinated. What's that mean for kids? For travel? For work? Experts weigh in.
-
The Biden administration announced a website and text line to help people find COVID-19 vaccines near where they live. It's a new and improved version of VaccineFinder, which launched in February.
-
The Food and Drug Administration says Abbott's BinaxNOW test and Quidel's QuickVue can be sold without a prescription.
-
The process of trying to get vaccinated can be confusing. A new platform from the federal government and private sector partners makes it easier to find a provider where you live. -
Vaccine eligibility has been expanded to all adults. Use NPR's tool to find out how to book an appointment. Plus, helpful advice about how to navigate the system.
-
The Food and Drug Administration gave emergency authorization to Ellume's rapid test in December, after it showed 96% accuracy in a U.S. clinical study.
-
The federal government announced several big changes to its vaccine plans, upending earlier guidance about whom to prioritize for the next phase.
-
Experts argue that pushing out more COVID-19 vaccine doses to states sooner may be a good idea, even if it means there's a chance some people's second dose gets delayed.
-
With case and death counts still surging, the pressure is on to vaccinate as many people as possible. Here's what it will take to get more Americans their shots, fast.
-
As COVID-19 hospitalizations surge, new data released by the federal government show how many hospitals are struggling with staffing.
